Key Record Dates
ClinicalTrials.gov Identifier: | NCT03042468 |
---|---|
Brief Title: | Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC |
First Submitted : | January 19, 2017 |
First Submitted that Met QC Criteria : | February 1, 2017 |
First Posted : | February 3, 2017 (Estimate) |
Results First Submitted : | September 30, 2022 |
Results First Submitted that Met QC Criteria : | November 16, 2022 |
Results First Posted : | December 13, 2022 |
Last Update Submitted that Met QC Criteria : | November 16, 2022 |
Last Update Posted : | December 13, 2022 |